Price Alert

Globus Medical Inc. (GMED)

NYSE: GMED · Real-Time Price · USD

60.48

2.42 (4.17%)

At close: Oct 03, 2025, 3:59 PM

60.73

0.40%

After-hours: Oct 03, 2025, 06:20 PM EDT

Globus Medical Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	2.63B	2.51B	2.52B	2.48B	2.24B	1.9B	1.57B	1.23B	1.1B	1.07B	1.02B	998.37M	973.94M	961.31M	958.1M	941.53M	927.9M	825.81M
Cost of Revenue	978.11M	989.39M	1.04B	1.04B	902.4M	718.84M	548.17M	353.28M	283.39M	275.38M	263.73M	254.93M	247.99M	243.36M	239.22M	238.29M	236.83M	223.63M
Gross Profit	1.65B	1.52B	1.48B	1.44B	1.33B	1.18B	1.02B	873.16M	813.56M	793.6M	759.12M	743.44M	725.95M	717.94M	718.88M	703.24M	691.07M	602.18M
Operating Income	281.49M	255M	165.99M	115.84M	68.15M	84.74M	133.14M	177.05M	236.34M	237.91M	227.95M	192.12M	185.75M	163.85M	171.95M	212.29M	208.97M	137.53M
Interest Income	2.37M	1.68M	n/a	n/a	7.92M	7.92M	7.92M	7.92M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	373.54M	232.95M	120.72M	121.05M	66.55M	93.65M	165.39M	202.51M	261.44M	257.31M	243.02M	200.73M	193.72M	172.11M	180.41M	222.79M	221.47M	150.59M
Net Income	356.65M	185.56M	102.98M	91.51M	40.67M	66.63M	122.87M	157.9M	204.34M	201.22M	190.17M	155.21M	154.99M	141.95M	149.19M	187.04M	184.05M	121.67M
Selling & General & Admin	1.04B	975.14M	981.05M	972.28M	887.75M	769.7M	643.41M	516.77M	467.14M	453.79M	432.12M	420.6M	410.47M	411.01M	408.15M	393.64M	386.34M	359.11M
Research & Development	141.8M	139.55M	163.75M	182.6M	176.55M	160.2M	124.01M	91.27M	80.64M	76.69M	73.02M	104.53M	101.68M	99.83M	97.35M	61.56M	60.13M	84.04M
Other Expenses	184.42M	150.4M	171.78M	169.04M	200.38M	165.01M	119.74M	88.08M	29.45M	25.22M	26.04M	26.18M	28.05M	43.25M	41.43M	35.75M	35.63M	21.5M
Operating Expenses	1.37B	1.27B	1.32B	1.33B	1.27B	1.09B	887.16M	696.11M	577.22M	555.69M	531.17M	551.31M	540.2M	554.09M	546.93M	490.95M	482.1M	464.65M
Interest Expense	1.59M	3.92M	5.82M	7.58M	6.81M	12.77M	17.37M	20.11M	24M	18.19M	14.23M	10.86M	9.06M	9.13M	9.3M	10.31M	11.29M	12.34M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	2.34B	2.26B	2.35B	2.36B	2.17B	1.81B	1.44B	1.05B	860.6M	831.07M	794.89M	806.24M	788.19M	797.46M	786.15M	729.24M	718.93M	688.28M
Income Tax Expense	16.89M	47.38M	17.74M	29.54M	25.88M	27.02M	42.52M	44.61M	57.11M	56.09M	52.85M	45.52M	38.73M	30.16M	31.22M	35.75M	37.42M	28.93M
Shares Outstanding (Basic)	135.21M	136.76M	136.73M	135.62M	135.19M	135.36M	137.88M	113.54M	100.37M	100.28M	99.97M	99.65M	100.67M	101.6M	101.5M	101.1M	100.45M	99.87M
Shares Outstanding (Diluted)	136.5M	139.77M	139.71M	138.06M	136.98M	135.36M	139.02M	115.25M	101.78M	102.2M	102.21M	101.42M	102.88M	104.08M	104.19M	104.42M	103.47M	102.42M
EPS (Basic)	2.62	1.35	0.75	0.67	0.30	0.64	1.18	1.57	2.04	2.01	1.89	1.54	1.53	1.40	1.48	1.87	1.85	1.23
EPS (Diluted)	2.60	1.34	0.75	0.67	0.30	0.64	1.17	1.55	2.01	1.97	1.86	1.51	1.49	1.36	1.43	1.81	1.80	1.19
EBITDA	618.8M	551.74M	472.42M	424.25M	394.65M	355.53M	346.58M	328.2M	318.48M	314.83M	304.5M	268.69M	263.11M	258.39M	264.73M	299.22M	295.75M	206.67M
EBIT	346.92M	286.9M	218.4M	167.3M	167.25M	173.64M	201.85M	237.72M	247.81M	245.31M	236.25M	200.52M	195.77M	188.84M	194.86M	229.28M	226.26M	141.2M
Depreciation & Amortization	271.88M	264.84M	254.02M	256.96M	227.4M	181.89M	144.73M	90.48M	70.67M	69.52M	68.25M	68.17M	67.34M	69.55M	69.87M	69.94M	69.49M	65.46M